Structural and Functional Analysis of Human Liver-Expressed Antimicrobial Peptide 2

被引:56
作者
Henriques, Sonia Troeira [1 ,2 ]
Tan, Chia Chia [1 ]
Craik, David J. [1 ]
Clark, Richard J. [1 ]
机构
[1] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia
[2] Univ Lisbon, Inst Mol Med, Fac Med, P-1649028 Lisbon, Portugal
基金
英国医学研究理事会;
关键词
antibiotics; membranes; NMR spectroscopy; peptides; protein structures; SURFACE-PLASMON RESONANCE; PHOSPHOLIPID-MEMBRANES; ANTIBACTERIAL PEPTIDES; LIPIDIC VESICLES; LEAP-2; PEP-1; NMR; TRANSLOCATION; PRP(106-126); INDUCTION;
D O I
10.1002/cbic.201000400
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human liver-expressed antimicrobial peptide 2 (LEAP-2) is a cationic antimicrobial peptide (CAMP) believed to have a protective role against bacterial infection. Little is known about the structure-activity relationships of LEAP-2 or its mechanism of action. In this study we describe the structure of LEAP-2, analyze its interaction with model membranes, and relate them to the antimicrobial activity of the peptide. The structure of LEAP-2, determined by NMR spectroscopy, reveals a compact central core with disorder at the N and C termini. The core comprises a beta-hairpin and a 3(10)- helix that are braced by disulfide bonds between Cys17-28 and Cys23-33 and further stabilized by a network of hydrogen bonds. Membrane-affinity studies show that LEAP-2 membrane binding is governed by electrostatic attractions, which are sensitive to ionic strength. Truncation studies show that the C-terminal region of LEAP-2 is irrelevant for membrane binding, whereas the N-terminal (hydrophobic domain) and core regions (cationic domain) are essential. Bacterial-growth-inhibition assays reveal that the antimicrobial activity of LEAP-2 correlates with membrane affinity. Interestingly, the native and reduced forms of LEAP-2 have similar membrane affinity and antimicrobial activities; this suggests that disulfide bonds are not essential for the bactericidal activity. This study reveals that LEAP-2 has a novel fold for a CAMP and suggests that although LEAP-2 exhibits antimicrobial activity under low-salt conditions, there is likely to be another physiological role for the peptide.
引用
收藏
页码:2148 / 2157
页数:10
相关论文
共 54 条
[1]   The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface [J].
Bals, R ;
Wang, XR ;
Zasloff, M ;
Wilson, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) :9541-9546
[2]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[3]   Cationic host defense (antimicrobial) peptides [J].
Brown, KL ;
Hancock, REW .
CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (01) :24-30
[4]   New applications of simulated annealing in X-ray crystallography and solution NMR [J].
Brunger, AT ;
Adams, PD ;
Rice, LM .
STRUCTURE, 1997, 5 (03) :325-336
[5]   Intramembrane molecular dipoles affect the membrane insertion and folding of a model amphiphilic peptide [J].
Cladera, J ;
O'Shea, P .
BIOPHYSICAL JOURNAL, 1998, 74 (05) :2434-2442
[6]   The synthesis, structural characterization, and receptor specificity of the α-conotoxin Vc1.1 [J].
Clark, Richard J. ;
Fischer, Harald ;
Nevin, Simon T. ;
Adams, David J. ;
Craik, David J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (32) :23254-23263
[7]   The dipole potential of phospholipid membranes and methods for its detection [J].
Clarke, RJ .
ADVANCES IN COLLOID AND INTERFACE SCIENCE, 2001, 89 :263-281
[8]   A vesicle capture sensor chip for kinetic analysis of interactions with membrane-bound receptors [J].
Cooper, MA ;
Hansson, A ;
Löfås, S ;
Williams, DH .
ANALYTICAL BIOCHEMISTRY, 2000, 277 (02) :196-205
[9]   Development of novel antibacterial peptides that kill resistant isolates [J].
Cudic, M ;
Condie, BA ;
Weiner, DJ ;
Lysenko, ES ;
Xiang, ZQ ;
Insug, O ;
Bulet, P ;
Otvos, L .
PEPTIDES, 2002, 23 (12) :2071-2083
[10]   Intracellular targets of antibacterial peptides [J].
Cudic, M ;
Otvos, L .
CURRENT DRUG TARGETS, 2002, 3 (02) :101-106